Company Profile

Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology. It develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. It is focused on the care of patients suffering from respiratory distress, whether associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma, and COVID-19 or other systemic conditions. Its device solutions are focused on High Velocity Nasal Insufflation, which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems, such as its Oxygen Assist Module, designed to automatically maintain a patients pulse oxygen saturation levels within a specified range for a defined period of time. Its digital solutions are focused on remote patient monitoring, using algorithms to predict respiratory episodes.

Employees

182

Sector

Advanced Medical Equipment & Technology

More about the company

04-21	Vapotherm Announces Fda 510(K) Clearance for the All Patient Circuit, Enabling High Velocity Therapy for Neonatal to Adult Patients	CI
12-09	Vapotherm, Inc. and Flight Medical Innovations Ltd. Announce Partnership to Bring the VentO2ux?? Ventilator to US Hospitals	CI
20/05/25	Vapotherm, Inc. Announces New Study Confirms its Unicorn Cannula Provides Comparable Efficacy at Lower Flow Rates	CI
20/09/24	Perceptive Discovery Fund LP, managed by Perceptive Advisors LLC completed the acquisition of Vapotherm, Inc. from a group of shareholders.	CI
13/08/24	Vapotherm, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
17/06/24	Vapotherm, Inc. announced that it expects to receive $50 million in funding from Perceptive Advisors LLC	CI
17/06/24	Perceptive Discovery Fund LP, managed by Perceptive Advisors LLC entered into definitive merger agreement to acquire Vapotherm, Inc. for $15.1 million.	CI
09/05/24	Vapotherm, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/04/24	Vapotherm, Inc. Enters into Amendment No. 7 to Loan and Security Agreement with SLR Investment Corp	CI
15/03/24	Vapotherm, Inc. to Unveil Access365 Home Ventilation Solution at MEDTRADE	CI
23/02/24	Vapotherm, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
23/02/24	Vapotherm, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
22/02/24	Vapotherm, Inc. Auditor Raises 'Going Concern' Doubt	CI

13/02/23	Piper Sandler Adjusts Price Target on Vapotherm to $0.50 From $1, Maintains Underweight Rating	MT
04/08/22	BTIG Downgrades Vapotherm to Neutral From Buy	MT
04/08/22	William Blair Downgrades Vapotherm to Market Perform From Outperform	MT
04/08/22	Piper Sandler Adjusts Vapotherm's Price Target to $2 From $2.50, Reiterates Underweight Rating	MT
24/06/22	BTIG Research Adjusts Vapotherm Price Target to $7 From $9, Maintains Buy Rating	MT

20/09/24	Vapotherm Announces Closing of Merger	PR
29/08/24	VAPOTHERM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vapotherm, Inc. - VAPO	BU
13/08/24	Vapotherm: Q2 Earnings Snapshot	AQ
13/08/24	Vapotherm Reports Second Quarter 2024 Financial Results	PR
01/07/24	Kuehn Law Encourages INFN, RPHM, VAPO, and PRFT Investors to Contact Law Firm	PR

Manager	Title	Age	Since
Joseph Army CEO	Chief Executive Officer	62	26/06/2012
Jessica Whittle CTO	Chief Tech/Sci/R&D Officer	-	01/02/2022
Dorota McKay AUD	Comptroller/Controller/Auditor	44	06/12/2021

Date	Insider	Type	Main position	Quantity	% Market Cap.
9/20/24 A	Joseph Army	Issuer sale	Chief Executive Officer	498,938	7.9895%
9/20/24 A	John Landry	Issuer sale	SVP & Chief Financial Officer	107,028	1.7138%
9/20/24 A	Dorota McKay	Issuer sale	Controller/Auditor	26,696	0.4275%

Vapotherm, Inc. Stock

Stocks

VAPO

US9221073052

Advanced Medical Equipment & Technology

Latest news : Vapotherm, Inc.

Analysts' recommendations: Vapotherm, Inc.

Press Releases: Vapotherm, Inc.

Quotes and Performance

Managers and Directors: Vapotherm, Inc.

Latest insider transactions

Other Advanced Medical Equipment & Technology

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VAPOTHERM, INC.	-0.46%	+0.46%	-	-	13.59M
THERMO FISHER SCIENTIFIC, INC.	-0.43%	+1.06%	+24.03%	+5.21%	213B
DANAHER CORPORATION	-0.61%	+1.82%	-1.07%	-23.54%	137B
INTUITIVE SURGICAL, INC.	+0.10%	+4.69%	-26.86%	+9.07%	125B
BOSTON SCIENTIFIC CORPORATION	+1.59%	+5.60%	-55.67%	-9.94%	69.46B
EDWARDS LIFESCIENCES CORPORATION	-0.98%	+4.16%	+8.50%	+4.90%	49.56B
SIEMENS HEALTHINEERS AG	-0.91%	+5.13%	-20.61%	-29.50%	47.2B
AGILENT TECHNOLOGIES, INC.	-0.25%	-0.14%	+21.91%	+12.97%	39.08B
WATERS CORPORATION	-0.79%	+0.70%	+29.97%	+37.50%	37.05B
ILLUMINA, INC.	+0.00%	+5.67%	+116.67%	+8.35%	31.03B
Average	-0.27%	+3.14%	+10.76%	+1.67%	83.19B
Weighted average by Cap.	-0.24%	+2.77%	+3.74%	-0.89%